Search research articles
Contact Us
Filters
Showing results (181-190 of 192) with videos related to
Page
of 20
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 21, 2017
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
T Yoshino, D Arnold, H Taniguchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 30, 2015
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
J S Chen, C Hsu, N J Chiang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2018
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
K Muro, F Lordick, T Tsushima, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2018
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
K Muro, E Van Cutsem, Y Narita, et al.
ESMO Open
|
January 26, 2025
Corrigendum to "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer": [ESMO Open 9 (2024) 103647]
L-T Chen, A Vogel, C Hsu, et al.
ESMO Open
|
September 4, 2024
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer
L-T Chen, A Vogel, C Hsu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2018
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
G K Abou-Alfa, S Qin, B-Y Ryoo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 19, 2020
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
L-T Chen, E Martinelli, A-L Cheng, et al.
ESMO Open
|
October 9, 2025
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer
D Tai, T Conroy, J J X Lee, et al.
ESMO Open
|
May 26, 2023
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer
T Yoshino, A Cervantes, H Bando, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 192) with videos related to
Sort By:
Page
of 20
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 21, 2017
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
T Yoshino, D Arnold, H Taniguchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 30, 2015
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
J S Chen, C Hsu, N J Chiang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2018
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
K Muro, F Lordick, T Tsushima, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2018
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
K Muro, E Van Cutsem, Y Narita, et al.
ESMO Open
|
January 26, 2025
Corrigendum to "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer": [ESMO Open 9 (2024) 103647]
L-T Chen, A Vogel, C Hsu, et al.
ESMO Open
|
September 4, 2024
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer
L-T Chen, A Vogel, C Hsu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2018
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
G K Abou-Alfa, S Qin, B-Y Ryoo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 19, 2020
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
L-T Chen, E Martinelli, A-L Cheng, et al.
ESMO Open
|
October 9, 2025
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer
D Tai, T Conroy, J J X Lee, et al.
ESMO Open
|
May 26, 2023
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer
T Yoshino, A Cervantes, H Bando, et al.
Page
of 20